Life Science News

Latest updates from the biotech and pharma world

Endpoints News 2025-12-01

Lilly slightly lowers self-pay prices for single-dose vials of Zepbound

Endpoints News 2025-12-01

Biopharma Sentiment Index | Q4 2025

Endpoints News 2025-12-01

"Heavy AI" is taking over biopharma | Signal Pulse Report

Endpoints News 2025-12-01

Introducing Endpoints Signal — intelligence for fresh biopharma insights

Endpoints News 2025-12-01

Gene writing startup Tessera strikes $150M partnership with Regeneron

Endpoints News 2025-12-01

Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqel

Endpoints News 2025-12-01

Generate:Biomedicines to start Phase 3 studies for TSLP antibody

Endpoints News 2025-11-26

Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS says

Endpoints News 2025-11-26

Lundbeck backs out of bidding war for sleep disorder biotech Avadel

Endpoints News 2025-11-26

Novo submits high-dose Wegovy for FDA approval using voucher

Endpoints News 2025-11-26

Delayed panel on vaccine injury payments to meet next month

Endpoints News 2025-11-26

Imfinzi's latest label expansion; FDA seeks more information on BiomX's nebulizer

Endpoints News 2025-11-26

FDA pushes back Ascendis' dwarfism drug decision date by three months

Endpoints News 2025-11-26

China's Zhongmou seeks to create a ‘one-size-fits-all’ rival to Luxturna

Endpoints News 2025-11-26

Cormorant eyes another $400M healthcare fund

Endpoints News 2025-11-26

Sanofi headquarters raided in broader French tax fraud investigation

Endpoints News 2025-11-26

Kallyope scraps one of two mid-stage migraine drugs

Endpoints News 2025-11-26

Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgAN

Endpoints News 2025-11-25

CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second round

Endpoints News 2025-11-25

What a team of ex-Amazon employees are building next in healthcare

19 / 21